NCT04680663

Brief Summary

Many patients undergoing long time surgery will manifest increased level of blood lactate. Hyperlactacidemia can cause disturbance of internal environment, then leading to increased complications and longer ICU stay, even death. For postoperative patients, we must ensure adequate perfusion in order to minimize the length of hyperglycemia and improve patients' outcomes. With regard to lactate, it provides information about prefusion, but not timely enough for its delay on reflecting hypoperfusion. And it's not real-time and non-invasive. Peripheral perfusion index (PPI) is an indicator reflecting hypoperfusion in critical patients. It is measured using pulse co-oximetry technology which is characterized by being real-time and noninvasive. PPI is defined as "the ratio of pulsatile blood flow to the non-pulsatile blood flow", mirroring the strength of blood flow and quality of perfusion at sensor site, reflecting perfusion state of the body part . In contrast to lactate value, it's real-time and easy to monitor.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
235

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Mar 2021

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 18, 2020

Completed
5 days until next milestone

First Posted

Study publicly available on registry

December 23, 2020

Completed
3 months until next milestone

Study Start

First participant enrolled

March 15, 2021

Completed
3.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 12, 2024

Completed
29 days until next milestone

Study Completion

Last participant's last visit for all outcomes

June 10, 2024

Completed
Last Updated

January 22, 2025

Status Verified

January 1, 2025

Enrollment Period

3.2 years

First QC Date

December 18, 2020

Last Update Submit

January 21, 2025

Conditions

Outcome Measures

Primary Outcomes (2)

  • Peripheral perfusion index

    at end of surgery as early predictor of postoperative complications .

    up to 48 hours

  • serum lactate level

    at end of surgery as early predictor of postoperative complications .

    up do 48 hours

Secondary Outcomes (5)

  • serum lactate level

    UP TO 30 day

  • Peripheral perfusion index

    UP TO 30 DAY

  • Postoperative complications

    up to 30 day

  • hemodynamic change

    up do 48 hours

  • heart rate

    up do 48 hours

Study Arms (2)

Non complications group

where the non-complicated patients is the patients running the normal postoperative course of surgery and without any need for intervention

Diagnostic Test: Peripheral Perfusion indexDiagnostic Test: serum lactate level

complications group

any deviation from the normal post-operative course

Diagnostic Test: Peripheral Perfusion indexDiagnostic Test: serum lactate level

Interventions

Peripheral Perfusion index is the ratio between pulsatile blood flow to non pulsatile blood flow or static blood in the peripheral tissue

Non complications groupcomplications group
serum lactate levelDIAGNOSTIC_TEST

Blood lactate (product of metabolism) level is maintained by a cycle of continuous production and metabolism allowing it to be kept within normal values

Non complications groupcomplications group

Eligibility Criteria

Age18 Years+
Sexall
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

This study will be designed to recruit patients scheduled for elective surgery with duration \> 120 minutes under general anaesthesia

You may qualify if:

  • Adult patients above 18 years of age.
  • Both genders
  • surgical time planned to be \> 120 minutes .
  • surgical time predicted to exceed the planned time and prolongation of surgical time \> 120 minutes occured will be included in the study .
  • ASA physical status of I-II
  • Patients scheduled for elective surgery under general anaesthesia .

You may not qualify if:

  • Refused to participate .
  • patient with disease affecting blood flow to the hands where probe will be applied .
  • patient with hand injuries so probe cannot be applied
  • Patient with sever renal and liver disease
  • Discharging against medical advice or reported death during ICU stay at first 48 hours after ICU admission .
  • Pregnancy or emergency surgery .
  • shortening of the planned surgical time to be less than 120 minutes

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Cairo university

Cairo, 11451, Egypt

Location

Study Officials

  • Amr s wahdan, MD

    Cairo university , Cairo, Egypt

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
30 Days
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor of Anesthesia, Pain management and Surgical ICU

Study Record Dates

First Submitted

December 18, 2020

First Posted

December 23, 2020

Study Start

March 15, 2021

Primary Completion

May 12, 2024

Study Completion

June 10, 2024

Last Updated

January 22, 2025

Record last verified: 2025-01

Locations